Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of human epididymis protein 4 (HE4) for assessing responsiveness of MUC 16-positive cancer treatment

Use of human epididymis protein 4 (HE4) for assessing responsiveness of MUC 16-positive cancer treatment

US Patent 11440969 · Granted Sep 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

End of route navigation system2025
CD8+ t cell based immunosuppressive tumor microenvironment detection method2024
Anti-Ly6G6D antibodies and methods of use2023
Diagnostic and therapeutic methods for cancer2022
Genetic variations associated with drug resistance2021
Wireless earphone2020
Headphone2020
Genetic variations associated with drug resistance2018
Method and device for adjusting frame rate of video recording2017
Compositions and methods for prostate cancer analysis2017